Diabetes revenue is still dropping but it’s not due to the strip business. Lifescan still hasn’t made a decision about selling so maybe they will modify the business.
Maybe the Co will try and pay a small lump sum and then will request UBI to start development on the next evolution of strips.
A T/O would work well because they would get UBI’s 1billion + strip production facility.
So much value around. I think Siemens will swoop first.
Add to My Watchlist
What is My Watchlist?
